Published in J Hyg (Lond) on June 01, 1983
Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine. J Clin Microbiol (1986) 2.67
Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a bayesian random-effects model. BMC Med Res Methodol (2010) 2.46
Interpretation of responses and protective levels of antibody against attenuated influenza A viruses using single radial haemolysis. J Hyg (Lond) (1984) 1.49
Durability of antibody responses after receipt of the monovalent 2009 pandemic influenza A (H1N1) vaccine among HIV-infected and HIV-uninfected adults. Vaccine (2011) 1.04
A cell culture-derived influenza vaccine provides consistent protection against infection and reduces the duration and severity of disease in infected individuals. Clin Infect Dis (2012) 0.87
Antibody response and persistence in volunteers following immunization with varying dosages of a trivalent surface antigen influenza virus vaccine. J Hyg (Lond) (1985) 0.83
A new approach to estimate vaccine efficacy based on immunogenicity data applied to influenza vaccines administered by the intradermal or intramuscular routes. Hum Vaccin (2010) 0.81
Biopolymer encapsulated live influenza virus as a universal CD8+ T cell vaccine against influenza virus. Vaccine (2010) 0.79
Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine. PLoS One (2016) 0.77
Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients. Int J Chron Obstruct Pulmon Dis (2007) 0.77
A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66
Determinants of immunity to influenza infection in man. Br Med Bull (1979) 4.62
Temperature-sensitive mutants of influenza virus. 3. Further characterization of the ts-1(E) influenza A recombinant (H3N2) virus in man. J Infect Dis (1973) 3.89
Evaluation of monovalent influenza vaccines. II. Observations during an influenza a-prime epidemic. Am J Hyg (1952) 3.13
Influenza antibody in human respiratory secretions after subcutaneous or respiratory immunization with inactivated virus. Nature (1968) 2.10
Antibody responses in nasal secretions and serum of elderly persons following local or parenteral administration of inactivated influenza virus vaccine. J Immunol (1969) 1.91
Dose-response relationship after immunization of volunteers with a new, surface-antigen-adsorbed influenza virus vaccine. J Infect Dis (1977) 1.25
A surface antigen influenza vaccine. 1. Purification of haemagglutinin and neuraminidase proteins. J Hyg (Lond) (1976) 1.14
A comparison of live and inactivated influenza A (H1N1) virus vaccines. 1. Short-term immunity. J Hyg (Lond) (1983) 1.07
Characterization and clinical evaluation of live influenza A vaccine prepared from a recombinant of the A/USSR/92/77 (H1N1) and the cold-adapted A/Ann Arbor/6/60 (H2N2) strains. Antiviral Res (1981) 0.94
Immune response in volunteers to intranasal inoculation with freeze-dried influenza Q/Hong Kong/68 vaccine. J Biol Stand (1975) 0.90
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ (1973) 10.70
Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ (1995) 9.26
Randomised, prospective, single-blind comparison of laparoscopic versus small-incision cholecystectomy. Lancet (1996) 8.78
How helpful is NHS direct? Postal survey of callers. BMJ (2000) 6.85
Psychological stress and susceptibility to the common cold. N Engl J Med (1991) 6.84
Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature (1985) 6.01
Protective effect of breast feeding against infection. BMJ (1990) 5.88
Variation in demand for accident and emergency departments in England from 1974 to 1985. J Epidemiol Community Health (1988) 5.86
Contribution of the private sector to elective surgery in England and Wales. Lancet (1984) 5.62
Molecular mechanisms of variation in influenza viruses. Nature (1982) 5.54
The Hong Kong-68 influenza A2 variant. Lancet (1968) 5.25
Use and expenditure on complementary medicine in England: a population based survey. Complement Ther Med (2001) 5.19
The DNA sequence and analysis of human chromosome 6. Nature (2003) 4.75
Designing conditions for in vitro formation of amyloid protofilaments and fibrils. Proc Natl Acad Sci U S A (1999) 4.71
A comparison of live and killed influenza-virus vaccines. Report to the Medical Research Council's Committee on Influenza and other Respiratory Virus Vaccines. Lancet (1968) 4.66
Experimental parvoviral infection in humans. J Infect Dis (1985) 4.62
Determinants of immunity to influenza infection in man. Br Med Bull (1979) 4.62
Undescribed toxin in pseudomembranous colitis. Br Med J (1977) 4.31
Analysis of the work of independent acute hospitals in England and Wales, 1981. Br Med J (Clin Res Ed) (1984) 4.29
The cohort effect and Helicobacter pylori. J Infect Dis (1993) 4.28
Evidence for host-cell selection of influenza virus antigenic variants. Nature (1983) 4.24
Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. Proc Natl Acad Sci U S A (1987) 4.19
The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res (1983) 4.06
Trials of Live Influenza Vaccine in the Royal Air Force. Br Med J (1962) 4.06
Synthesis of methyl-mercury compounds by extracts of a methanogenic bacterium. Nature (1968) 4.01
Gene products that promote mRNA turnover in Saccharomyces cerevisiae. Mol Cell Biol (1992) 4.00
Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci U S A (1984) 3.98
Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. Virus Res (2004) 3.95
Single-radial-hemolysis: a new method for the assay of antibody to influenza haemagglutinin. Applications for diagnosis and seroepidemiologic surveillance of influenza. Bull World Health Organ (1975) 3.88
Inhibition of haemaggregation by lepromin and other mycobacterial substances. Nature (1967) 3.84
The polypeptide composition of influenza A viruses. Virology (1971) 3.79
A quantitative, single-radial-diffusion test for immunological studies with influenza virus. J Gen Virol (1972) 3.69
Location and primary structure of a major antigenic site for poliovirus neutralization. Nature (1983) 3.64
Work of a district ethical committee. Br Med J (1979) 3.64
Popular marathons: forecasting casualties. Br Med J (Clin Res Ed) (1982) 3.59
Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin. J Med Virol (2003) 3.23
The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect (1990) 3.12
Characterization of the ribonucleoprotein and neuraminidase of influenza A viruses by immunodiffusion. J Gen Virol (1969) 3.11
The relationship between upper respiratory infections and hospital admissions for asthma: a time-trend analysis. Am J Respir Crit Care Med (1996) 3.10
Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response. Br Med J (1972) 3.10
The receptor-binding and membrane-fusion properties of influenza virus variants selected using anti-haemagglutinin monoclonal antibodies. EMBO J (1987) 3.03
Inhibition of respiratory virus infection by locally applied interferon. Lancet (1973) 3.02
Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms. J Clin Microbiol (1993) 3.01
Predictors of future falls in Parkinson disease. Neurology (2010) 3.00
Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J Virol (1989) 2.89
Disease mapping models: an empirical evaluation. Disease Mapping Collaborative Group. Stat Med (2001) 2.88
Vaccination prevents latent HSV1 infection of mouse brain. Neurobiol Aging (2001) 2.85
Change in obstetric practice in response to fear of litigation in the British Isles. Lancet (1991) 2.78
Immunity to influenza in ferrets. I. Response to live and killed virus. Br J Exp Pathol (1972) 2.78
Characterization of virulent and avirulent A/chicken/Pennsylvania/83 influenza A viruses: potential role of defective interfering RNAs in nature. J Virol (1985) 2.75
Role of viruses in febrile convulsions. Arch Dis Child (1979) 2.72
Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs. Virology (1985) 2.71
Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. J Hyg (Lond) (1971) 2.70
Investigetion into the attenuation of influenza viruses by serial passage. Br Med J (1968) 2.67
Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study. Lancet (1969) 2.66
Confirmatory assay increases specificity of the chlamydiazyme test for Chlamydia trachomatis infection of the cervix. J Clin Microbiol (1990) 2.65
Biological cycles for toxic elements in the environment. Science (1974) 2.62
Immunogenicity and acceptability of a human diploid-cell culture rabies vaccine in volunteers. Lancet (1975) 2.61
Differences in durations of stay for surgery in the NHS and private sector in England and Wales. Br Med J (Clin Res Ed) (1985) 2.61
Structural changes in the haemagglutinin which accompany egg adaptation of an influenza A(H1N1) virus. Virology (1987) 2.58
Antibody responses to antigenic determinants of influenza virus hemagglutinin. I. Thymus dependence of antibody formation and thymus independence of immunological memory. J Exp Med (1974) 2.54
Using the SF-36 and Euroqol on an elderly population. Qual Life Res (1996) 2.53
Provision of first contact care out of hours in four urban areas in England. Br Med J (Clin Res Ed) (1985) 2.51
Incidence of herpes simplex virus types 1 and 2 isolated in patients with herpes genitalis in Sheffield. Br J Vener Dis (1982) 2.48
Antiviral activity in milk of possible clinical importance. Lancet (1976) 2.47
Relation between early introduction of solid food to infants and their weight and illnesses during the first two years of life. BMJ (1993) 2.46
An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J Biol Stand (1977) 2.46
Serological studies on infections by respiratory viruses of the inhabitants of Tristan da Cunha. J Hyg (Lond) (1967) 2.42
Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol (2000) 2.41
The metabolism of protocatechuate by Pseudomonas testosteroni. Biochem J (1968) 2.41
Monoclonal antibodies which block cellular receptors of poliovirus. Virus Res (1984) 2.40
VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci (2000) 2.38
Genetics of L-proline utilization in Escherichia coli. J Bacteriol (1981) 2.37
Use of evidence based leaflets to promote informed choice in maternity care: randomised controlled trial in everyday practice. BMJ (2002) 2.35
A new virus cultivated only in organ cultures of human ciliated epithelium. Arch Gesamte Virusforsch (1966) 2.34
Common colds on Tristan da Cunha. J Hyg (Lond) (1971) 2.34
Declining T-cell immunity to influenza, 1977-82. Lancet (1983) 2.34
Effect of rubella vaccination programme on serological status of young adults in United Kingdom. Lancet (1979) 2.31
A study of the movement of nurses and nursing skills between the NHS and the private sector in England and Wales. Int J Nurs Stud (1988) 2.31
The degradation of trans-ferulic acid by Pseudomonas acidovorans. Biochemistry (1970) 2.29
Proline transport and osmotic stress response in Escherichia coli K-12. J Bacteriol (1986) 2.29
Quality of life measurements in patients with malignant disease: a review. J R Soc Med (1986) 2.28
New aspects of liposomes. Biochim Biophys Acta (1976) 2.27
A virus from epidemic vomiting disease. Br Med J (1972) 2.26
Antibody responses to antigenic determinants of influenza virus hemagglutinin. II. Original antigenic sin: a bone marrow-derived lymphocyte memory phenomenon modulated by thymus-derived lymphocytes. J Exp Med (1974) 2.25
Longer term clinical and economic benefits of offering acupuncture care to patients with chronic low back pain. Health Technol Assess (2005) 2.21
Toxic oligomers and islet beta cell death: guilty by association or convicted by circumstantial evidence? Diabetologia (2010) 2.21
Organ cultures in virology. Prog Med Virol (1969) 2.21
Isolation of rhinoviruses and coronaviruses from 38 colds in adults. J Med Virol (1980) 2.21
Symbiotic properties of C4-dicarboxylic acid transport mutants of Rhizobium leguminosarum. J Bacteriol (1983) 2.19
Prevalence of hypoxaemic chronic obstructive lung disease with reference to long-term oxygen therapy. Lancet (1985) 2.18
Segregation of antigenic and biological characteristics during influenza virus recombination. J Gen Virol (1972) 2.18
Circulation of influenza viruses and paramyxoviruses in waterfowl originating from two different areas of North America. Bull World Health Organ (1985) 2.18
Evidence for a new type-specific structural antigen of the influenza virus particle. J Gen Virol (1972) 2.17
Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes. Lancet (1987) 2.15